Search Results 841-850 of 17177 for treatment resistant depression
Is there any change in the pattern of use, such as increasing or stopping use? Has the person recently appeared depressed, extremely sad or withdrawn? Has the ...
... treatment such as immunotherapy, target therapy and chemotherapy in lung cancer and mechanisms of resistance. The information generated from this study will ...
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies · Share · Facebook · Twitter.
A Study to Evaluate Feasibility of In Vivo Sensitivity Screen Using Direct Tumor Microinjection and FDG-PET in Patients with Relapsed/Refractory Non-Hodgkin ...
... treatments. It is also used together with paclitaxel for the first-line treatment of HER2-overexpressing metastatic breast cancer. Trastuzumab-dttb ...
A Study of R-ICE and Lenalidomide for Treating Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma. Print details. Share; Facebook ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...
For people who have anorexia, being underweight may interfere with the effectiveness of medicines they take for other conditions, including depression and ...
Consensus-based recommendations for the diagnosis and treatment of anxiety and depression ... Temporal Encephalocele: A Treatable Etiology of Drug-Resistant ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.